Christopher John Recklitis, PhD, MPH

Director of Research, Perini Family Survivors' Center

Senior Psychologist

Associate Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-5124
Fax: 617-582-8068
Preferred Contact Method: email


Treatment Centers
Clinical Interests
Health psychology, Mental health outcomes of oncology patients


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215


Board Certifications
Certified Health Care Provider
Licensed Psychologist
Boston Children's Hospital, Pediatric Health Services Research
Harvard School of Public Health, Clinical Effectiveness
Christopher J. Recklitis, Ph.D., MPH is Director of Research and Support Services for the Perini Family Survivors Center at Dana-Farber, and Associate Professor of Pediatrics at Harvard Medical School. He completed doctoral degree in clinical psychology at Boston University, and his Masters in Public Health at the Harvard School of Public Health. Dr. Recklitiss research is focused on understanding the psychological late-effects of cancer, the development of effective screening measures for detecting distress, and the best methods for encouraging health protective behaviors in cancer survivors. He is the Principal Investigator of Project REACH, a longitudinal study of health outcomes in several hundred locally treated cancer survivors. His work has been supported by grants from the National Cancer Institute, Lance Armstrong Foundation, American Foundation for the Prevention of Suicide, and the Childhood Brain Tumor Foundation.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.